Mirae Asset Global Investments
CDLX icon

Mirae Asset Global Investments’s Cardlytics CDLX Stock Holding History

Mirae Asset Global Investments’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,877
Closed -$173K – 2462
2023
Q4 		$173K Hold
1,877
– – ﹤0.01% 2365
2023
Q3 		$310K Hold
1,877
– – ﹤0.01% 2114
2023
Q2 		$119K Buy
+1,877
New +$114K ﹤0.01% 2468
2023
Q1 		– Sell
-1,401
Closed -$80.9K – 2534
2022
Q4 		$80.9K Hold
1,401
– – ﹤0.01% 2486
2022
Q3 		$132K Buy
+1,401
New +$199K ﹤0.01% 2448

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Mirae Asset Global Investments's CDLX Position: Q1 2024 in Review

Mirae Asset Global Investments sold out of Cardlytics (CDLX) in Q1 2024, closing a stake of 1,877 shares — an estimated $173K sold.

Mirae Asset Global Investments first reported a position in CDLX in Q3 2022 and held it in 5 quarters. The position peaked at $310K in Q3 2023. 144 funds tracked by Wall St. Rank hold CDLX as of Q1 2024.

  • Mirae Asset Global Investments reported no remaining Cardlytics position as of Q1 2024 after selling out during the quarter.
  • Mirae Asset Global Investments sold 1,877 Cardlytics shares in Q1 2024, an estimated $173K.
  • Mirae Asset Global Investments first reported a position in Cardlytics in Q3 2022 and held it in 5 quarters.
  • Mirae Asset Global Investments's Cardlytics position peaked at $310K in Q3 2023.
  • 144 funds tracked by Wall St. Rank held Cardlytics as of Q1 2024.

Based on Mirae Asset Global Investments's 13F filing for Q1 2024, filed 1 May 2024.